Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment
https://jamanetwork.com/journals/jam...tm_term=081121
Hopefully, booster shot (third dose) for at risk people will be authorized this Friday. This would go a long way (for most people) in improving/restore vaccine respond.